NovoCure Ltd. NVCR
$17.68
▲ +0.40% 24H
About
Novocure Ltd. is a global oncology company that develops and commercializes Tumor Treating Fields (TTFields), an innovative, non-invasive cancer therapy using alternating electric fields tuned to specific frequencies to disrupt cancer cell division while sparing healthy tissue. Its commercialized products, including Op…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountrySwitzerland
Employees1,605
TickerNVCR
Statistics
Market Cap$2.05B
Revenue (TTM)$655.4M
Net Income-$136.2M
Net Margin-20.8%
EPS$-1.22
P/E-14.72
P/S3.04
P/B6.20
EV/EBITDA-10.42
ROE-50.0%
Dividend Yield—
Price$17.68
Data: Twelve Data · Revenue = mcap / P/S